CYTEK BIOSCIENCES INC. - COMMON STOCK
3.7100
30-April-25 16:45:00
15 minutes delayed
Stocks
-0.0400
-1.07%
Today's range
3.6100 - 3.7500
ISIN
N/A
Source
NASDAQ
-
Cytek Biosciences Reports Third Quarter 2023 Financial Results
07 Nov 2023 16:05:01 By Nasdaq GlobeNewswire
-
Cytek Biosciences to Report Third Quarter 2023 Financial Results on November 7, 2023
19 Oct 2023 16:05:00 By Nasdaq GlobeNewswire
-
Cytek® Biosciences Achieves ISO 13485 Certification at Headquarters
27 Sep 2023 09:00:00 By Nasdaq GlobeNewswire
-
Cytek Biosciences to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
20 Sep 2023 16:15:00 By Nasdaq GlobeNewswire
-
20 Sep 2023 09:00:00 By Nasdaq GlobeNewswire
-
Cytek® Biosciences Launches Educational Roadshow Focused on Spectral Flow Cytometry
14 Sep 2023 09:00:00 By Nasdaq GlobeNewswire
-
Cytek Biosciences to participate in the Morgan Stanley 21st Annual Global Healthcare Conference
06 Sep 2023 16:10:00 By Nasdaq GlobeNewswire
-
Cytek Biosciences Appoints Dr. Philippe Busque Senior Vice President of Global Sales & Services
28 Aug 2023 05:30:00 By Nasdaq GlobeNewswire
-
Cytek Biosciences to Participate in the UBS MedTech, Tools and Genomics Summit
10 Aug 2023 16:05:02 By Nasdaq GlobeNewswire
-
Cytek Biosciences Reports Second Quarter 2023 Financial Results
08 Aug 2023 16:05:01 By Nasdaq GlobeNewswire
-
Cytek Biosciences to Report Second Quarter 2023 Financial Results on August 8, 2023
20 Jul 2023 17:26:35 By Nasdaq GlobeNewswire
-
Cytek Biosciences to Participate in the 44th Annual Goldman Sachs Healthcare Conference
31 May 2023 16:05:00 By Nasdaq GlobeNewswire
-
Cytek Biosciences Announces $50 Million Stock Repurchase Program
19 May 2023 09:00:00 By Nasdaq GlobeNewswire
-
16 May 2023 08:00:00 By Nasdaq GlobeNewswire
-
Cytek Biosciences Reports First Quarter 2023 Financial Results
09 May 2023 16:05:03 By Nasdaq GlobeNewswire
-
Cytek Biosciences to Report First Quarter 2023 Financial Results on May 9, 2023
20 Apr 2023 16:05:00 By Nasdaq GlobeNewswire
-
Cytek® Biosciences Introduces New 20-Color AML Panel
07 Mar 2023 17:00:00 By Nasdaq GlobeNewswire
-
Cytek Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results
28 Feb 2023 16:05:01 By Nasdaq GlobeNewswire
-
Sale of Flow Cytometry and Imaging Business From DiaSorin to Cytek® Biosciences Completed
28 Feb 2023 09:21:38 By Nasdaq GlobeNewswire
-
Cytek® Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorin
13 Feb 2023 16:07:03 By Nasdaq GlobeNewswire